A phase I study of an immunomodulatory thalidomide analogue (CC4047) in relapse/refractory multiple myeloma

S Schey, R Jones, K Raj, M Streetley

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)98 - 98
Number of pages1
JournalExperimental Hematology
Volume30
Issue number6
Publication statusPublished - 2002

Cite this